The 4th International Electronic Conference on Antibiotics
The 4th International Electronic Conference on Antibiotics
Challenges and Strategies for the Antibiotic Resistance Crisis
Part of the International Electronic Conference on Antibiotics series
Event's Timezone: Central European Summer Time
21st January 2025
21st March 2025
16th May 2025
Antibiotics Stewardship, Antimicrobial Use, Antibiotics Resistance, Novel Antimicrobial Agents, Multidisciplinary Antimicrobial Strategies, Antibiotic Clinical Studies, Artificial Intelligence Strategies
Welcome from the Chairs
We expect that participants of this conference will be able to exchange novel, provocative ideas by presenting short oral presentations on research and development and discoveries, as well as emphasizing challenges facing antibiotic resistance as a public health crisis.
Download the conference banner and share it with your colleagues!
Kind regards,
Prof. Dr. Manuel Simões,
Dr. Marc Maresca,
CNRS, Aix-Marseille University, Centrale Marseille, iSm2, Marseille, France
Chairs of the 4th International Electronic Conference on Antibiotics
Event Chairs
Department of Chemical Engineering, Faculty of Engineering, University of Porto, Portugal
keywords: antimicrobial agents; emerging antimicrobial strategies; antimicrobial resistance; biofilms; plant secondary metabolites
Manuel Simões has a PhD in Chemical and Biological Engineering and is currently Associate Professor with Habilitation at the Faculty of Engineering of the University of Porto, where he is Pro-Director. He has more than 180 papers published in journals indexed in JCR (h-index = 48), 4 books (1 as author and 3 as editor) and more than 40 chapters in books. His research focusses on biofilms and antimicrobial action and resistance. He has been highlighted as a highly cited author in 2020 and 2021 by Clarivate Analytics. SCOPUS ID: 55608338000; Orcid ID: 0000-0002-3355-4398.
keywords: mycotoxins; fungal metabolites; antimicrobial; anticancer; antinflammatory; antioxidant
Dr. Marc Maresca is currently a researcher at Aix-Marseille Université. He received his Ph.D. in Biochemistry from the Université Paul Cézanne (France, 2003) working on food contaminants named mycotoxins. In 2003, he moved to England to work on enteropathogenic E coli in Brendan Keny’s lab. Then, he moved back to France to continue his work on mycotoxins and their effects on human health. He is currently working at Aix-Marseille Université and his research aims to identify and develop new molecules—natural, synthetic, or bio-inspired—with antimicrobial properties. He focuses on antimicrobial peptides and their mimics as well as on plant derivatives and evaluates, in addition to their antimicrobial effects, additional activities such as anti-inflammatory and anti-tumorigenic effects.
Event Committee
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
Dr. Anthony W. Coleman studied at Huddersfield New College and qualified by competitive examination for admission to the University of Oxford. He was affiliated to Jesus College from 1972-76 obtaining an Honours degree in Chemistry. Publications 260 in Science Citation Index, 150 Invited and Plenary Talks and 22 Patents (3 licenced).
biomechanics; silver nanoparticle antibiotic action; metal ions in epigenetics; bioactive supramolecular systems; 3D printing and biofi
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He has headed several academic research teams (CNRS, INSERM and University), as well as a combined academic–industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins and microbes. He so far contributed to several books in toxicology and virology, and more than 180 scientific articles, 180 communications, and 55 patents in both biology and chemistry. He acts as the Editor-in-Chief of the journals Coronaviruses, Infectious Disorders – Drug Targets, and Venoms and Toxins. He is a member of 66 Editorial Boards of scientific journals, such as Peptides, Molecules, Antibiotics, Frontiers in Pharmacology, and the Journal of Biological Chemistry. He also reviewed articles submitted for publication in >100 international journals and acts as an expert for numerous national and international institutions. He won the ‘Citizen of the Year Award’ from The Nouvel Economiste (1994) for his work on antivirals. He is a member of a dozen scientific societies, such as the ‘American Peptide Society’ (charter member), ‘European Peptide Society’, ‘American Society for Microbiology’, ‘Biochemical Society’ and ‘New-York Academy of Sciences’.
antimicrobial peptides; antibacterial; antibiotics; structure-activity relationships; bacteriocins; drug design; peptide engineering
School of Food Science and Engineering, South China University of Technology, Guangzhou, China
S3. Epidemiology, Prevalence and Mechanisms of Antibiotic Resistance and Cross-Resistance biofilm
Dr. Xu obtained a B.S. and Ph.D. from South China University of Technology in 2005 and 2011, respectively, and has worked as an Assistant Professor since 2011. Dr. Xu was awarded a Top 100 National Outstanding Doctoral Dissertation in 2014. His major research interests include microbial biofilm, antimicrobial resistance, polymicrobial interaction, and rapid detection. Dr. Xu is the co-founder and co-president of Asia-Pacific Biofilms (previously known as ChinaBiofilms). Dr. Xu has published more than 100 manuscripts as first or correspondence author, with the total IF > 260, citation > 5,000, H-Index as 42, and I-10 Index as 82. Professor, South China University of Technology, Guangzhou, China. Assistant Visiting Scientist, University of Maryland, College Park, United States. Distinguished Visiting Professor, Rajamangala University of Technology Phra Nakhon, Bangkok, Thailand. Adjunct Professor, National Institute of Fundamental Science, Kandy, Sri Lanka.
foodborne microorganisms; antimicrobial resistance; pathogenicity and virulence; stress response; quorum sensing; polymicrobial interacti
Operations Manager, JMI Laboratories, A Subsidiary of Element Materials Technology, North Liberty, USA
S3. Epidemiology, Prevalence and Mechanisms of Antibiotic Resistance and Cross-Resistance
Dr. Papp-Wallace is the Operations Manager at JMI Laboratories in North Liberty, Iowa. JMI Laboratories is a CLIA-certified clinical microbiology reference laboratory that provides support for preclinical drug development, surveillance studies, and bacterial and fungal phase I – IV clinical trials. She completed her doctorate in Pharmacology at Case Western Reserve University, followed by postdoctoral training in microbiology and antimicrobial resistance at Veterans Affairs Northeast Ohio Healthcare System in Cleveland, Ohio under the direction of Dr. Robert A. Bonomo. Her research interests include understanding mechanisms of antimicrobial resistance in Gram-negative bacteria and identifying strategies to overcome resistance. As Research Scientist at the Veterans Affairs Northeast Ohio Healthcare System and tenured Associate Professor in the Department of Medicine Division of Infectious Diseases and HIV Medicine at Case Western Reserve University, she led projects that focused on structure-function relationships of clinically important β-lactamases from Gram negatives using microbiological and biochemical testing as well as structural biology with >80 peer-reviewed manuscripts. Dr. Papp-Wallace is Section Editor-in-Chief for Section "Mechanism and Evolution of Antibiotic Resistance" for Antibiotics. She is also an editor for Microbiology Spectrum and serves on the editorial board for Antimicrobial Agents and Chemotherapy.
serine β-lactamases, β-lactams; β-lactamase inhibitors; Burkholderia; carbapenem-resistant gram negatives; structure-activity relationships; enz
Université de Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of
Lille, Lille, France
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
Department of Life Sciences, Faculty of Science and Technology, The University of the West Indies (The UWI), St. Augustine Campus, Trinidad and Tobago
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
Milena Mechkarska is currently a Senior Lecturer at The University of the West Indies (The UWI), St. Augustine Campus, Trinidad and Tobago. She obtained her MSc in Biotechnology with a Major Genetic and Cellular Engineering from Sofia University (Bulgaria) and holds a PhD in Biochemistry from Wageningen University (The Netherlands). She joined The UWI in 2016 where she established a new research direction focused on development of nature-inspired therapeutic agents at the Department of Life Sciences (DLS), Faculty of Science and Technology (FST). During the last 14 years she has maintained a close collaboration with Professor J Michael Conlon (Ulster University) working on characterization of multifunctional host-defence peptides from frog-skin secretions, as well as scorpion and snake venoms (view her ORCID and Google scholar profiles). Additionally, she collaborates with researchers from France, Italy, Spain, Austria, United Arab Emirates and Bulgaria. She is a member of the Editorial Board of Antibiotics and serves as a reviewer for several other journals, such as Peptides, Toxicon, Comparative Biochemistry and Physiology, The Protein Journal, Biochimie and Nature Communications. Dr. Mechkarska is currently International Ambassador of the Biochemical Society UK at The UWI, facilitating involvement of both undergraduate and postgraduate students in research and outreach.
antimicrobial peptides; bioactive host-defence peptides; immunomodulators; venoms; novel therapeutics; drug development; host-pathogen
Department of Chemistry, Royal College of Surgeons in Ireland (RCSI), Dublin, Ireland
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
arc Devocelle completed his PhD at the University of Lille (France) and subsequently joined RCSI (Royal College of Surgeons in Ireland) in 1999. In 2000, he established, and led since, the Peptide Synthesis Laboratory at RCSI, a national facility for the synthesis of peptides and their modifications. He is currently an Associate Professor of Chemistry at RCSI. His research is focused on (cationic) Antimicrobial Peptides, developing various derivatives tailored to different applications.
antimicrobial peptides; prodrugs; peptidomimetics
Local Unit of Imola, Department of Public Health, Health Service of the Emilia—Romagna Region, 40026 Imola, Italy
S6. Antibiotic Clinical Studies, Pharmacokinetics and Pharmacodynamics
He graduated in Chemistry in 1996 and then specialized in Analytical Chemistry. Ph.D. in Medicine in 2002, since then he works for the Public Health Systems in Italy as a Biochemist and Analytical Chemist (Toxicology and Pharmacology Lab). He has conducted Research in Biochemistry, Biomedicine, Nanotechnology and Pharmacology at the University of Bologna and in Public Healthcare Institutions abroad.
anticancer antibiotics; tumor microbiota; pharmacokinetics of anticancer drugs and antibiotics; therapeutic drug monitoring; chromatography-mass spectrometry; analytical chemisty
Emergency Medicine, Fondazione Policlinico, Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
S6. Antibiotic Clinical Studies, Pharmacokinetics and Pharmacodynamics
medical and surgical emergencies in older adults; acute diverticulitis; acute pancreatitis; sepsis, infection in emergency; procalcitonin; trauma; head trauma; early warning scores; COVID-19; COVID-19 in the elderly
Session Chairs
Prof. Dr. Reza Nassiri
Department of Pharmacology/Toxicology, Michigan State University, East Lansing, MI, USA
antibiotics in clinical practice; antibiotic resistance; antibiotic stewardship; nosocomial infections; global health; infections diseases; SARS-CoV-2 infection
Dr. Efstathios Giaouris
Department of Food Science and Nutrition, Faculty of the Environment, University of the Aegean, Greece
food hygiene and safety; natural antimicrobials; sustainable microbial control; beneficial microorganisms; biofilms; intercellular interactions and communication; bacterial stress adaptation; virulence and pathogenesis
Prof. Dr. Nicholas Dixon
Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, NSW 2522, Australia
bacterial DNA replication; protein-protein interactions; protein-DNA interactions; enzymes; antibiotic drug discovery
Prof. Dr. Jordi Vila
Department of Clinical Microbiology, Hospital Clinic, Barcelona, Spain
multidrug gram-negative bacteria; design new antibiotics; mechanisms of resistance; acinetobacter baumannii
Prof. Dr. Serena Riela
Department of Chemistry, University of Catania, Via Andrea Doria, 6, 95125 Catania, Italy
organic chemistry; synthesis; drug delivery; coniugates; hallosyte nanotubes; carrier systems; nanomaterials; biocompatible materials
Prof. Dr. Manuel Simões
Department of Chemical Engineering, Faculty of Engineering, University of Porto, Portugal
antimicrobial agents; emerging antimicrobial strategies; antimicrobial resistance; biofilms; plant secondary metabolites
Dr. Marc Maresca
CNRS, Aix-Marseille University, Centrale Marseille, iSm2, Marseille, France
mycotoxins; fungal metabolites; antimicrobial; anticancer; antinflammatory; antioxidant
Invited Speakers
Director I Unit of Emerging Infectious Disease and at High Contagiousness, AORN Ospedali dei Colli - P.O. D.Cotugno
Highly experienced Infectious Disease Specialist with over 20 years in clinical and academic settings. Currently serving as the Director of the Infectious Disease Unit at Regional Center of Infectious Disease P.O.D.COtugno at AORN Monaldi-Cotugno-CTO, Naples, Italy. Extensive expertise in infectious disease management, antimicrobialstewardship and epidemiology, with a particular focus on high-contagion diseases, viral hepatitis, healthcare-associated infections and AI and ML applied to Infectious Disease and Epidemiology. Proven leadership in regional and national health initiatives, including COVID-19 response and antimicrobial resistance strategies based on innovative strategy as AI and ML algorithms.
Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy
Elena Maria Varoni graduated cum laude in Dentistry from the University of Milan (Italy), in 2008. She, then, obtained her PhD in "Biotechnologies for human health" in 2012, at the University of Eastern Piedmont (Novara, Italy), mainly focusing in preclinical research on innovative biomaterials and drug delivery systems. She had important experiences abroad as visiting scholar at the Universidad de Granada (Granada, Spain) and at the University of Laval (Quebec City, Canada). In 2012, she worked as postdoc at McGill University (Montreal, Canada), where she came back, in 2016, as visiting scientist, after becoming a researcher the University of Milan. Since 2020, she has been Associate Professor at the University of Milan. Here, she divides her activity between teaching, healthcare support and research activities. Since October 2023, she has been appointed as President of the Degree Course in Dental Hygiene at the same University. She has been former spokesperson of the Young Scientists Forum of the European Society of Biomaterials. She co-authored more than 100 publications on international journals. During her career, Prof. Varoni has received important scientific awards, including the "Henry Goldman Prize” of the Italian Society of Periodontology (2013), the “Young Scientist/Clinician Prize” of the European Association of Oral Medicine (2010) and "The medical and dental Futureshapers challenge" award from the Dental and Medical Board of Milan (2019).
Sessions
S2. Antibiotics and One Health
S3. Epidemiology, Prevalence and Mechanisms of Antibiotic Resistance and Cross-Resistance
S4. Novel Antimicrobial Agents: Discovery, Design, Synthesis and Action
S5. Multidisciplinary Antimicrobial Strategies: Materials, Peptides, Bacteriophages and Repurposing
S6. Antibiotic Clinical Studies, Pharmacokinetics and Pharmacodynamics
S7. Clinical and Environmental Impact of Bacterial Biofilms
S8. Artificial Intelligence Strategies to Tackle Antibiotic Resistance
Registration
The registration for ECA2025 will be free of charge! The registration includes attendance to all conference sessions.
If you are registering several people under the same registration, please do not use the same email address for each person, but their individual university email addresses. Thank you for your understanding.
Please note that the submission and registration are two separate parts. Only scholars who registered can receive a link to access the conference live streaming. The deadline for registration is 16th May 2025 .
Instructions for Authors
ECA2025 will accept abstracts only. The accepted abstracts will be available online on Sciforum.net during and after the conference.
2. All abstracts should be submitted and presented in clear, publication-ready English with accurate grammar and spelling.
3. You may submit multiple abstracts. However, only one abstract will be selected for oral presentation.
4. The abstracts submitted to this conference must be original and novel, without prior publication in any journals or it will not be accepted to this conference.
1. The submitting author must ensure that all co-authors are aware of the contents of the abstract.
2. Please select only one presenter for each submission. If you would like to change the presenter after submission, please email us accordingly.
Note: We only accept live presentations.
2. File format: PDF (.pdf).
3. Size in pixel: 1,080 width x 1,536 height–portrait orientation.
4. Size in cm: 38.1 width x 54.2 height–portrait orientation.
5. Font size: ≥16.
You can use our free template to create your poster. The poster template can be downloaded here.
Poster Gallery
Authors who wish to present a poster are invited to send it to the conference email at eca2025@mdpi.com. All posters will be permanently exhibited online in the Poster Gallery.
It is the author's responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state "The authors declare no conflicts of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Any financial support for the study must be fully disclosed in the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe authors should retain the copyright to their scholarly works. Hence, by submitting an abstract to this conference, you retain the copyright to the work, but you grant MDPI the non-exclusive right to publish this abstract online on the Sciforum.net platform. This means you can easily submit your full paper (with the abstract) to any scientific journal at a later stage and transfer the copyright to its publisher if required.
Publication Opportunities
Proceeding Paper Publication
Full author names
Affiliations (including full postal address) and authors' e-mail addresses
Abstract
Keywords
Introduction
Methods
Results and Discussion
Conclusions
Acknowledgements
References
Event Awards
The Awards
Number of Awards Available: 5
The Best Oral Presentation Award is given to the paper judged to make the most significant oral contribution to the conference.
The Best Poster Award is given to the submission judged to make the most significant and interesting poster for the conference.
There will be five winners selected for these awards. Best Oral Presentation Award will receive a certificate and 300 CHF and Best Poster Award will receive a certificate and 200 CHF.
Sponsors and Partners
Organizers
Media Partners
